Differential effects of Ca2+ on proliferation of stomach, colonic, and pancreatic cancer cell lines in vitro

Y. S. Guo, E. Draviam, Courtney Townsend, Pomila Singh

Research output: Contribution to journalArticle

Abstract

Calcium intake inhibits growth of colon cancer in vivo, the mechanisms of which are not fully elucidated. The objective of this study was to determine whether Ca2+ directly affects the growth of colon cancer cells in vitro and to compare the effects of Ca2+ on the growth of several gastroenteropancreatic cancer cells, including mouse colon cancer (MC-26), human colon cancer (LoVo and WIDR), human gastric cancer (AGS and SII), and human pancreatic cancer (PANC-1 and MIA) cells. All tumor cell lines tested grew in medium containing low concentration (approx 0.16 mM) of Ca2+. Higher concentrations of Ca2+ significantly inhibited the growth of all three colon cancer cell lines tested but had no significant effect on proliferation of the stomach and pancreatic cancer cell lines. Growth of AGS cells, in the presence of 0.1 or 0.5 mM EGTA (resulting in the loss of the extracellular Ca2+) was similar to that observed in the absence of EGTA, indicating that AGS cells were relatively insensitive to loss of extracellular Ca2+. In the presence of TMB-8, an inhibitor of intracellular Ca2+ release, the growth of colonic cancer cell lines was inhibited in a dose-dependent manner, indicating that a minimum basal level of intracellular Ca2+ was required for continued proliferation of colon cancer cells. The stomach cancer cell lines (AGS) was once again less sensitive to the effects of TMB-8 than were the colon cancer cells, indicating an inherent difference in Ca2+ requirements and sensitivity to Ca2+ for growth of different gastroenteropancreatic cancer cells in vitro. These results further demonstrate that in contrast to normal cells, all tumor cells tested can continue to proliferate in the presence of low concentrations of extracellular Ca2+ (approx < 0.16 mM) and that higher concentrations of Ca2+ specifically and directly inhibit growth of human and mouse colon cancer cells. The latter results may provide an additional explanation for the mechanism by which intake of dietary calcium decreases the risk of developing colon cancers.

Original languageEnglish (US)
Pages (from-to)149-157
Number of pages9
JournalNutrition and Cancer
Volume14
Issue number2
StatePublished - 1990

Fingerprint

pancreatic neoplasms
Pancreatic Neoplasms
Colonic Neoplasms
Stomach Neoplasms
stomach
cell lines
calcium
colorectal neoplasms
Cell Line
Growth
stomach neoplasms
Egtazic Acid
neoplasm cells
In Vitro Techniques
Dietary Calcium
Neoplasms
Tumor Cell Line
human growth
mice
cells

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Oncology
  • Food Science

Cite this

Differential effects of Ca2+ on proliferation of stomach, colonic, and pancreatic cancer cell lines in vitro. / Guo, Y. S.; Draviam, E.; Townsend, Courtney; Singh, Pomila.

In: Nutrition and Cancer, Vol. 14, No. 2, 1990, p. 149-157.

Research output: Contribution to journalArticle

@article{a7eb0938667543058ad1550345439c66,
title = "Differential effects of Ca2+ on proliferation of stomach, colonic, and pancreatic cancer cell lines in vitro",
abstract = "Calcium intake inhibits growth of colon cancer in vivo, the mechanisms of which are not fully elucidated. The objective of this study was to determine whether Ca2+ directly affects the growth of colon cancer cells in vitro and to compare the effects of Ca2+ on the growth of several gastroenteropancreatic cancer cells, including mouse colon cancer (MC-26), human colon cancer (LoVo and WIDR), human gastric cancer (AGS and SII), and human pancreatic cancer (PANC-1 and MIA) cells. All tumor cell lines tested grew in medium containing low concentration (approx 0.16 mM) of Ca2+. Higher concentrations of Ca2+ significantly inhibited the growth of all three colon cancer cell lines tested but had no significant effect on proliferation of the stomach and pancreatic cancer cell lines. Growth of AGS cells, in the presence of 0.1 or 0.5 mM EGTA (resulting in the loss of the extracellular Ca2+) was similar to that observed in the absence of EGTA, indicating that AGS cells were relatively insensitive to loss of extracellular Ca2+. In the presence of TMB-8, an inhibitor of intracellular Ca2+ release, the growth of colonic cancer cell lines was inhibited in a dose-dependent manner, indicating that a minimum basal level of intracellular Ca2+ was required for continued proliferation of colon cancer cells. The stomach cancer cell lines (AGS) was once again less sensitive to the effects of TMB-8 than were the colon cancer cells, indicating an inherent difference in Ca2+ requirements and sensitivity to Ca2+ for growth of different gastroenteropancreatic cancer cells in vitro. These results further demonstrate that in contrast to normal cells, all tumor cells tested can continue to proliferate in the presence of low concentrations of extracellular Ca2+ (approx < 0.16 mM) and that higher concentrations of Ca2+ specifically and directly inhibit growth of human and mouse colon cancer cells. The latter results may provide an additional explanation for the mechanism by which intake of dietary calcium decreases the risk of developing colon cancers.",
author = "Guo, {Y. S.} and E. Draviam and Courtney Townsend and Pomila Singh",
year = "1990",
language = "English (US)",
volume = "14",
pages = "149--157",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Differential effects of Ca2+ on proliferation of stomach, colonic, and pancreatic cancer cell lines in vitro

AU - Guo, Y. S.

AU - Draviam, E.

AU - Townsend, Courtney

AU - Singh, Pomila

PY - 1990

Y1 - 1990

N2 - Calcium intake inhibits growth of colon cancer in vivo, the mechanisms of which are not fully elucidated. The objective of this study was to determine whether Ca2+ directly affects the growth of colon cancer cells in vitro and to compare the effects of Ca2+ on the growth of several gastroenteropancreatic cancer cells, including mouse colon cancer (MC-26), human colon cancer (LoVo and WIDR), human gastric cancer (AGS and SII), and human pancreatic cancer (PANC-1 and MIA) cells. All tumor cell lines tested grew in medium containing low concentration (approx 0.16 mM) of Ca2+. Higher concentrations of Ca2+ significantly inhibited the growth of all three colon cancer cell lines tested but had no significant effect on proliferation of the stomach and pancreatic cancer cell lines. Growth of AGS cells, in the presence of 0.1 or 0.5 mM EGTA (resulting in the loss of the extracellular Ca2+) was similar to that observed in the absence of EGTA, indicating that AGS cells were relatively insensitive to loss of extracellular Ca2+. In the presence of TMB-8, an inhibitor of intracellular Ca2+ release, the growth of colonic cancer cell lines was inhibited in a dose-dependent manner, indicating that a minimum basal level of intracellular Ca2+ was required for continued proliferation of colon cancer cells. The stomach cancer cell lines (AGS) was once again less sensitive to the effects of TMB-8 than were the colon cancer cells, indicating an inherent difference in Ca2+ requirements and sensitivity to Ca2+ for growth of different gastroenteropancreatic cancer cells in vitro. These results further demonstrate that in contrast to normal cells, all tumor cells tested can continue to proliferate in the presence of low concentrations of extracellular Ca2+ (approx < 0.16 mM) and that higher concentrations of Ca2+ specifically and directly inhibit growth of human and mouse colon cancer cells. The latter results may provide an additional explanation for the mechanism by which intake of dietary calcium decreases the risk of developing colon cancers.

AB - Calcium intake inhibits growth of colon cancer in vivo, the mechanisms of which are not fully elucidated. The objective of this study was to determine whether Ca2+ directly affects the growth of colon cancer cells in vitro and to compare the effects of Ca2+ on the growth of several gastroenteropancreatic cancer cells, including mouse colon cancer (MC-26), human colon cancer (LoVo and WIDR), human gastric cancer (AGS and SII), and human pancreatic cancer (PANC-1 and MIA) cells. All tumor cell lines tested grew in medium containing low concentration (approx 0.16 mM) of Ca2+. Higher concentrations of Ca2+ significantly inhibited the growth of all three colon cancer cell lines tested but had no significant effect on proliferation of the stomach and pancreatic cancer cell lines. Growth of AGS cells, in the presence of 0.1 or 0.5 mM EGTA (resulting in the loss of the extracellular Ca2+) was similar to that observed in the absence of EGTA, indicating that AGS cells were relatively insensitive to loss of extracellular Ca2+. In the presence of TMB-8, an inhibitor of intracellular Ca2+ release, the growth of colonic cancer cell lines was inhibited in a dose-dependent manner, indicating that a minimum basal level of intracellular Ca2+ was required for continued proliferation of colon cancer cells. The stomach cancer cell lines (AGS) was once again less sensitive to the effects of TMB-8 than were the colon cancer cells, indicating an inherent difference in Ca2+ requirements and sensitivity to Ca2+ for growth of different gastroenteropancreatic cancer cells in vitro. These results further demonstrate that in contrast to normal cells, all tumor cells tested can continue to proliferate in the presence of low concentrations of extracellular Ca2+ (approx < 0.16 mM) and that higher concentrations of Ca2+ specifically and directly inhibit growth of human and mouse colon cancer cells. The latter results may provide an additional explanation for the mechanism by which intake of dietary calcium decreases the risk of developing colon cancers.

UR - http://www.scopus.com/inward/record.url?scp=0025193467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025193467&partnerID=8YFLogxK

M3 - Article

C2 - 2216899

VL - 14

SP - 149

EP - 157

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 2

ER -